ArticleScientific reports2026
Temperature-dependent gating pathways in TRPV3.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Inactivation Switch for Run-up in TRPV2.Research square · 2026Article
- Thermodynamic coupling between cold and heat activations of TRPV2.Scientific reports · 2026Article
Corrections and comments
- Update of
Authors and funding
1 author.
Funding
Abstract
Both hot and cold sensations of the homotetrameric thermosensitive transient receptor potential vanilloid 1-4 (TRPV1-4) channels have been predicted by a single Gibbs-Helmholtz equation for a change in molar heat capacity. However, the heat capacity model has not been examined for TRPV3 channels involving inactivation. Given the mirrored heat and cold sensitivity in TRPV1 with a shared starter, the same case should be detected for TRPV3. To test this hypothesis, the temperature-dependent quaternary and tertiary structures of oxidized TRPV3 in the presence and absence of the natural cannabinoid tetrahydrocannabivarin (THCV) at the active vanilloid site were characterized along a lipid-dependent gating pathway. Further thermoring analyses showed that gating state-dependent thermostability allowed oxidized TRPV3 to be activated and then inactivated by THCV only below 30 °C. However, no inactivation would be observed above 30 °C once the lipid at the active vanilloid site was released by THCV binding. More importantly, despite the distinct tertiary and quaternary structures in cold- and heat-evoked open states, the initial cold activation of oxidized TRPV3 still shared a similar thermosensitivity with heat activation. Therefore, such two temperature-dependent gating pathways of oxidized TRPV3 actually still resulted from symmetric cold and heat activation, supporting the heat capacity model, regardless of the subsequent inactivation. In contrast, the initial inactivation resulted in unpredictable pore dilation along with a tetramer-to-pentamer transition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.